Earth Science Tech (ETST) Cash & Current Investments (2013 - 2026)
Earth Science Tech (ETST) posted Cash & Current Investments of $2.2 million for Q1 2026, up 355.67% on a QoQ basis from $473330.0 in Q4 2025, and up 1.8% year-over-year from $2.1 million in Q1 2025.
Earth Science Tech (ETST) Cash & Current Investments (2013 - 2026) Analysis & Trends
Earth Science Tech's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- Quarterly Cash & Current Investments rose 1.8% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 1.8% YoY) and the FY2026 annual result came in at $2.2 million, up 1.8% from the prior year.
- Cash & Current Investments was $2.2 million for Q1 2026 at Earth Science Tech, up from $473330.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $2.2 million in Q1 2026 and bottomed at $1205.0 in Q3 2022.
- A 5-year average of $755249.5 and a median of $473330.0 in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 95.22% — and 2023, when it jumped 15472.61%.
- Earth Science Tech's Cash & Current Investments stood at $24188.0 in 2022, then soared by 750.5% to $205718.0 in 2023, then surged by 688.95% to $1.6 million in 2024, then plunged by 70.84% to $473330.0 in 2025, then jumped by 355.67% to $2.2 million in 2026.
- Business Quant data shows ETST's Cash & Current Investments at $2.2 million in Q1 2026, $473330.0 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Earth Science Tech | 35.17 Mn | 33.01 Mn | 6.27 Mn | 2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 473,330.00 |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 929,814.00 |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 707,073.00 |
| Dec 31, 2023 | 205,718.00 |
| Sep 30, 2023 | 187,650.00 |
| Jun 30, 2023 | 91,989.00 |
| Mar 31, 2023 | 35,756.00 |
| Dec 31, 2022 | 24,188.00 |
| Sep 30, 2022 | 1,205.00 |
| Jun 30, 2022 | 35,756.00 |
| Mar 31, 2022 | 26,942.00 |
| Dec 31, 2021 | 10,586.00 |
| Sep 30, 2021 | 25,217.00 |
| Jun 30, 2021 | 9,869.00 |